MedPath

E-cigarette vs. Nicotine Inhaler Comparisons

Not Applicable
Completed
Conditions
Smoking
Interventions
Other: Electronic Cigarette
Other: Nicotrol Inhaler
Registration Number
NCT02294617
Lead Sponsor
Rutgers, The State University of New Jersey
Brief Summary

The goal of this study is to get information from current smokers about how they feel towards both the electronic cigarette (e-cigarette) and the nicotine oral inhaler. This will include beliefs, harms, appeal, ease of use, enjoyment, and their use for helping people stop smoking.

Detailed Description

Subjects will be seen at Baseline, then 3-days post-baseline, then 9 days post-baseline for post product use questionnaires and carbon monoxide monitoring. The time frame for follow up is 6 months post Baseline visit.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
41
Inclusion Criteria
  • Subjects will be smokers 18 years or older, who have had no previous experience with either the e-cigarette or the nicotine oral inhaler, and will be recruited from the local community. They can currently smoke any amount or frequency and with any level of motivation to stop smoking.
Exclusion Criteria
  • Exclusion criteria include recent (within 2 weeks) myocardial infarction or angina, poorly controlled asthma/chronic obstructive pulmonary disease , active substance abuse, pregnancy, or current use of any other cessation medications

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Electronic CigaretteElectronic CigaretteSubject will use the electronic cigarette for 3 days.
Nicotrol InhalerNicotrol InhalerSubjects will use the Nicotine Inhaler for 3 days.
Primary Outcome Measures
NameTimeMethod
Satisfaction of devices on Likert Scale6 months (August 2012-December 2013)

The goal of this study is to gather data from current smokers regarding their perceptions and experiences with both the e-cigarette and the nicotine oral inhaler over a 6 month time period.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath